BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH
344 results:

  • 1. Impact of Short-Term Creatine Supplementation on Muscular Performance among breast cancer Survivors.
    Parsowith EJ; Stock MS; Kocuba O; Schumpp A; Jackson K; Brooks AM; Larson A; Dixon M; Fairman CM
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613014
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Not Available].
    Ammar N; Ezzairi F; Omri N; Ammar A; Ezzi O; Ben El Ghali T; Mahjoub M; Chabchoub I; Ben Ahmed S; Njah M
    Tunis Med; 2024 Mar; 102(3):157-163. PubMed ID: 38545711
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index.
    Sachdev R; Shearn-Nance G; Vu L; Bensken WP; Douglas SL; Koroukian SM; Rose J
    J Geriatr Oncol; 2024 Mar; 15(2):101706. PubMed ID: 38320468
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long-term outcomes with HLX01 (HanliKang
    Qin Y; Song Y; Wang D; Bai O; Feng J; Sun X; Qiu L; Yang J; Yang Y; Wang Z; Hu J; Wang H; Su H; Jin Z; Qian W; Jin C; Zhang M; Yu D; Liu L; Chen G; Li Y; Sun T; Jin J; Bao H; Du X; Zhou H; Fu G; Shi Y
    BMC Cancer; 2024 Jan; 24(1):124. PubMed ID: 38267866
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ.
    Wu H; Jiang Y; Tian H; Ye X; Cui C; Shi S; Chen M; Ding Z; Li S; Huang Z; Luo Y; Peng Q; Xu J; Dong F
    Comput Methods Programs Biomed; 2024 Mar; 245():108039. PubMed ID: 38266556
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. In Utero Exposure to Maternal COVID-19 Vaccination and Offspring Neurodevelopment at 12 and 18 Months.
    Jaswa EG; Cedars MI; Lindquist KJ; Bishop SL; Kim YS; Kaing A; Prahl M; Gaw SL; Corley J; Hoskin E; Cho YJ; Rogers E; Huddleston HG
    JAMA Pediatr; 2024 Mar; 178(3):258-265. PubMed ID: 38252445
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diversity in online resources for breast reconstruction: What do patients see?
    Lee E; Yesantharao P; Long C; He W; Landford W; Xun H; Sacks JM; Cooney CM; Broderick KP
    J Plast Reconstr Aesthet Surg; 2024 Feb; 89():154-163. PubMed ID: 38199217
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage breast cancer.
    Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
    JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].
    Deng J; Pan T; Zhou G; Gao Y; Peng W; Wei W; Lü C
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1657-1664. PubMed ID: 37933640
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The direct medical cost of breast cancer management in a provincial hospital of Papua New Guinea: A cost of illness study of consecutive patients from 2017 to 2022.
    Umo I; Kulai M; Umo P; James K; Ikasa R
    J Cancer Policy; 2023 Dec; 38():100447. PubMed ID: 37813161
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy.
    Šušak Sporiš I; Božina N; Klarica Domjanović I; Sporiš D; Bašić S; Bašić I; Lovrić M; Ganoci L; Trkulja V
    Fundam Clin Pharmacol; 2024 Apr; 38(2):351-368. PubMed ID: 37793994
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
    Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
    BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ultrasound and clinicopathological characteristics of breast cancer for predicting axillary lymph node metastasis.
    Bai X; Wang Y; Song R; Li S; Song Y; Wang H; Tong X; Wei W; Ruan L; Zhao Q
    Clin Hemorheol Microcirc; 2023; 85(2):147-162. PubMed ID: 37694357
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spare the Nipple: A Systematic Review of Tumor Nipple-Distance and Oncologic Outcomes in Nipple-Sparing Mastectomy.
    Youn S; Lee E; Peiris L; Olson D; Lesniak D; Rajaee N
    Ann Surg Oncol; 2023 Dec; 30(13):8381-8388. PubMed ID: 37620525
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. ESTIMATION OF SERUM FERROPORTIN AND LIVER ENZYMES IN breast cancer PATIENTS.
    Aziz Z; Sarhat E; Zaidan Z
    Georgian Med News; 2023 Jun; (339):37-41. PubMed ID: 37522771
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic breast cancer.
    Rugo HS; Liu X; Li B; McRoy L; Chen C; Layman RM; Brufsky A
    Oncologist; 2023 Oct; 28(10):866-874. PubMed ID: 37487056
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Improved concordance of challenging human epidermal growth factor receptor 2 dual in-situ hybridisation cases with the use of a digital image analysis algorithm in breast cancer.
    Gough M; Liu C; Srinivasan B; Wilkinson L; Dunk L; Yang Y; Schreiber V; Tuffaha H; Kryza T; Hooper JD; Lakhani SR; Snell CE
    Histopathology; 2023 Oct; 83(4):647-656. PubMed ID: 37366040
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Leadership and Impostor Syndrome in Surgery.
    Iwai Y; Yu AYL; Thomas SM; Fayanju OA; Sudan R; Bynum DL; Fayanju OM
    J Am Coll Surg; 2023 Oct; 237(4):585-595. PubMed ID: 37350479
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Validating the PROMIS cognitive function short form in cancer survivors.
    Henneghan AM; Van Dyk K; Zhou X; Moore RC; Root JC; Ahles TA; Nakamura ZM; Mandeblatt J; Ganz PA
    Breast Cancer Res Treat; 2023 Aug; 201(1):139-145. PubMed ID: 37330430
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Comparison of different cyclin-dependent kinase inhibitors and KI-67 levels on survival and toxicity in breast cancer treatment.
    Bayram E; Selvi O; Köşeci T; Mete B; Yaslıkaya Ş; Paydaş S
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5230-5239. PubMed ID: 37318497
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.